Neuroendocrine responses as an indicator of recurrence liability in primary affective illness.
D001714:Bipolar Disorder / Q000188:drug therapy*; D006801:Humans; D007328:Insulin; D008094:Lithium / Q000627:therapeutic use*; D011388:Prolactin / Q000097:blood*; D012008:Recurrence
D007328:Insulin; D011388:Prolactin; D008094:Lithium